纤维化间歇性肺病的治疗:当前的方法和未来的方向
Kerri A Johannson1, Nazia Chaudhuri2, Ayodeji Adegunsoye3
1Departments of Medicine and Community Health Sciences, Snyder Institute for Chronic Diseases, University of Calgary, Calgary, AB, Canada.
本综述总结了目前纤维化间歇性肺病 (ILD) 的治疗方法,涵盖了新的发现和临床试验. 它还讨论了管理这些渐进性肺部疾病的挑战和未来研究.
科学领域:
- 肺病学
- 纤维化间歇性肺部疾病 (ILD)
背景情况:
- 纤维性间歇性肺部疾病 (ILD) 是一种具有高发病率和死亡率的渐进性肺部疾病.
- 最近的进展改善了对ILD的理解,表征和治疗策略.
研究的目的:
- 总结目前用于纤维性ILD的治疗方法.
- 突出最近的发现,改变实践的临床试验,以及在ILD管理中的持续挑战.
主要方法:
- 对纤维性ILD治疗的最新进展进行文献综述.
- 目前药物和非药物治疗策略的综合.
- 讨论不断发展的概念和未来的研究方向.
主要成果:
- 在过去的十年中,在了解和治疗纤维性内脏病方面取得了重大进展.
- 确定主要的药物和非药物治疗方案.
- 概述当前该领域的争议和挑战.
结论:
- 目前针对纤维性内脏病的治疗策略有了显著的发展.
- 持续的研究和应对挑战对于改善患者的结果至关重要.
- 未来的方向将集中在新的治疗方法和个性化治疗方法上.
更多相关视频
07:38A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice
Published on: April 13, 2018
06:03Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
Published on: May 9, 2025
相关概念视频
Cystic Fibrosis: Management
Sinus disease and chronic...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
COPD: Management Using Bronchodilators and Corticosteroids
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
